Company
Avicanna Inc
TSE:AVCN
Avicanna Inc is an international biopharmaceutical company focused on the advancement and commercialization of evidence-based cannabinoid products for the global medical and pharmaceutical market segments. The company has an established scientific platform including R&D and clinical development which lead to the commercialization of more than thirty products globally. Medical Cannabis & Wellness Products: RHO Phyto is a full formulary of products including oral, sublingual, topical, and transdermal deliveries with controlled dosing, enhanced absorption and stability studies supported by pre-clinical data. Pharmaceutical Pipeline: Leveraging its scientific platform, vertical integration, and real-world evidence, Avicanna has created a pipeline of patent-pending drug candidates that are indication-specific and in various stages of clinical development and commercialization.
33 stories · page 1 of 2
Avicanna stock climbs on Shoppers Drug Mart partnership plus more daily small cap movers
A Medical Cannabis by Shoppers partnership deal lifted shares of Avicanna Inc Tuesday plus other big percentage movers on news from the small and micro cap space